Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8dac68a44dafdbe174c88dd5d4906a1d |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36157 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0504 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-3614 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-3606 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36125 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36146 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36017 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-37247 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0551 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-37241 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36007 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-372 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-05 |
filingDate |
2017-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2019-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48ef3b244157e2c90a645fe779e4f381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_842f51ba84001d42bbe3b60935f771f3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a24e96e610b83123bf994f66781f319 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a153935fa3b2c64812d94c85648bb92 |
publicationDate |
2019-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-10406369-B2 |
titleOfInvention |
Electromyographic lead positioning and stimulation titration in a nerve stimulation system for treatment of overactive bladder |
abstract |
The present invention provides improved methods for positioning of an implantable lead in a patient with an integrated EMG and stimulation clinician programmer. The integrated clinician programmer is coupled to the implantable lead, wherein the implantable lead comprises at least four electrodes, and to at least one EMG sensing electrode minimally invasively positioned on a skin surface or within the patient. The method comprises delivering a test stimulation at a stimulation amplitude level from the integrated clinician programmer to a nerve tissue of the patient with a principal electrode of the implantable lead. Test stimulations are delivered at a same stimulation amplitude level for a same period of time sequentially to each of the four electrodes of the implantable lead. A stimulation-induced EMG motor response is recorded with the integrated clinician programmer for each test stimulation on each electrode of the implantable lead via the at least one pair of EMG sensing electrodes so as to facilitate initial positioning of the implantable lead at a target stimulation region. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11116985-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11439829-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11730411-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11497916-B2 |
priorityDate |
2014-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |